JAIDS: Journal of Acquired Immune Deficiency Syndromes

Articles Available on Medscape

• Factors Associated With Severity of COVID-19 Disease in a Multicenter Cohort of People With HIV in the United States, March-December 2020
  Learn more about the risk factors associated with COVID-19 severity among people living with HIV.

  July 20, 2022

• Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV
  Do the results from this study support the use of this combination HIV treatment during the pregnancy and postpartum period?

  July 12, 2022

• Safety and Tolerability of Once Daily Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide for Postexposure Prophylaxis After Sexual Exposure
  Is this PEP regimen a safe and effective means of preventing HIV infection after high-risk sexual exposure?

  April 27, 2022

• Lower Incidence of HIV-1 Blips Observed During Integrase Inhibitor-Based Combination Antiretroviral Therapy
  A new study observes a lower number of viral blips during INSTI-based treatment compared with other ART regimens.

  March 30, 2022

• Bictegravir/Emtricitabine/Tenofovir Alafenamide Efficacy in Participants With Preexisting Primary Integrase Inhibitor Resistance Through 48 Weeks of Phase 3 Clinical Trials
  Is this HIV treatment option an effective means of achieving virologic suppression among those who are resistant to INSTI-based regimens?

  March 10, 2022

Table of Contents

2020 -

• Mood disorders and increased risk of non-communicable disease in adults with HIV. 

  January 03, 2020

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]